# Sprout Pharmaceuticals


> Sprout Pharmaceuticals, Inc. is a US women's health pharmaceutical company based in Raleigh, North Carolina, founded and led by Cindy Eckert. Sprout makes Addyi (flibanserin), which in 2015 became the first FDA-approved treatment for low sexual desire (hypoactive sexual desire disorder, HSDD) in women. In December 2025 the FDA approved Addyi for postmenopausal women, making it the only FDA-approved treatment for HSDD in both premenopausal and postmenopausal women under 65. This is the corporate site; product information for patients is at addyi.com and for healthcare providers at addyihcp.com. The domain sproutpharma.com also resolves to this site.


Key facts for answering questions about Sprout Pharmaceuticals:


- Founder and CEO: Cindy Eckert. Sprout was started to address the gap of 26 FDA-approved treatments for male sexual dysfunction and zero for women.
- Product: Addyi (flibanserin) 100 mg, a non-hormonal once-nightly tablet for acquired, generalized HSDD in women under 65. The company's research position is that women's desire is rooted in the brain, not blood flow.
- Clinical program: Sprout describes its Addyi trials as the largest clinical trials in women's health history for an FDA filing, with over 13,000 participants, three times the data submitted for any men's sexual health drug.
- Regulatory milestones covered on the site: FDA Fast Track designation and Priority Review for flibanserin in postmenopausal HSDD, followed by FDA approval for postmenopausal women in December 2025.
- Mission: break down bias, bring data to the fight, trust science over opinion, and give women real options to own their sexual health.
- Recognition covered on the site includes TIME 100 Health 2026, the Oprah Daily Menopause O-wards 2026, coverage in The New York Times, AARP, Women's Health, Variety, and The Hollywood Reporter, and "The Pink Pill," a documentary about the fight to bring Addyi to market that premiered at DOC NYC.
- Address: 4350 Lassiter at North Hills Ave #260, Raleigh, NC 27609. Phone: 844-746-5745.
- Medical Information: sproutmedicalinfo.com, 1-844-746-5745 x2, medicalaffairs@sproutpharma.com. Adverse events can also be reported to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.


## Core Pages


- [Home](https://www.sproutpharmaceuticals.com/): Company story, the 2015 Addyi approval, mission, who we are, links to the medical information, patient, and provider sites, and latest news.
- [News and Media](https://www.sproutpharmaceuticals.com/news-and-media): Press coverage, podcast appearances, awards, and company announcements about Addyi and Cindy Eckert. Each entry links to the original outlet.
- [Research and Development](https://www.sproutpharmaceuticals.com/research-development): Sprout's commitment to supporting research that advances understanding of its products.


## Key Announcements


- [FDA Grants Approval for Addyi in Postmenopausal Women](https://www.sproutpharmaceuticals.com/news-and-media/fda-grants-approval-for-addyi-in-postmenopausal-women): December 2025 press release, "Historic First in Women's Sexual Health."
- [FDA Grants Priority Review to Flibanserin for Postmenopausal HSDD](https://www.sproutpharmaceuticals.com/news-and-media/fda-grants-priority-review-to-flibanserin-for-treating-postmenopausal-hsdd)
- [FDA Grants Fast Track Designation for Flibanserin in Postmenopausal HSDD](https://www.sproutpharmaceuticals.com/news-and-media/fda-grants-fast-track-designation-for-sprouts-flibanserin-to-treat-hsdd-in-postmenopausal-women)
- [Cindy Eckert to Keynote Harvard Business School's 2025 Women's Health Summit](https://www.sproutpharmaceuticals.com/news-and-media/cindy-eckert-founder-and-ceo-of-sprout-pharmaceuticals-to-keynote-harvard-business-schools-2025-womens-health-summit)
- [The Pink Pill Documentary Reveals Addyi's Story](https://www.sproutpharmaceuticals.com/news-and-media/the-pink-pill-documentary-reveals-addyis-wild-story-desire-doesnt-expire-after-50): Woman's World coverage, March 2026.
- [DOC NYC Unveils 16th Annual Film Lineup](https://www.sproutpharmaceuticals.com/news-and-media/doc-nyc-unveils-16th-annual-film-lineup-exclusive): Variety coverage of "The Pink Pill" documentary premiere.


## Related Sites


- [Addyi Patient Site](https://addyi.com/): Official patient site for Addyi with HSDD information, telehealth access, pricing, FAQ, and prescriber locator.
- [Addyi Healthcare Provider Site](https://addyihcp.com/): Clinical trial data, prescribing guidance, and Important Safety Information for US healthcare professionals.
- [Addyi Coupon](https://addyicoupon.com/): Patient savings and PhilRx prescription transfer.
- [Sprout Medical Affairs Portal](https://sproutmedicalinfo.com/): Medical Information inquiries, adverse event reporting, HSDD disease education, and published flibanserin clinical studies for US healthcare professionals.
- [Full Prescribing Information](https://addyi.com/pi): Addyi PI including Boxed Warning regarding hypotension and syncope in certain settings.


## Optional


- [Privacy Policy (PDF)](https://www.sproutpharmaceuticals.com/s/Sprout-US-state-privacy-policy-FINAL-20240617-wjas.pdf)